Free Trial

Pheton (PTHL) Competitors

Pheton logo
$0.67 +0.04 (+5.88%)
As of 01:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PTHL vs. IRIX, BTCY, ICU, HSDT, ALUR, SINT, CODX, NVNO, IINN, and CTCX

Should you be buying Pheton stock or one of its competitors? The main competitors of Pheton include IRIDEX (IRIX), Biotricity (BTCY), SeaStar Medical (ICU), Solana (HSDT), Allurion Technologies (ALUR), Sintx Technologies (SINT), Co-Diagnostics (CODX), enVVeno Medical (NVNO), Inspira Technologies OXY B.H.N. (IINN), and Carmell (CTCX). These companies are all part of the "medical equipment" industry.

Pheton vs. Its Competitors

Pheton (NASDAQ:PTHL) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

In the previous week, Pheton had 1 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for Pheton and 1 mentions for IRIDEX. Pheton's average media sentiment score of 1.00 beat IRIDEX's score of 0.00 indicating that Pheton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pheton
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IRIDEX
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pheton has a net margin of 0.00% compared to IRIDEX's net margin of -10.95%. Pheton's return on equity of 0.00% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
PhetonN/A N/A N/A
IRIDEX -10.95%-386.93%-17.42%

20.1% of IRIDEX shares are owned by institutional investors. 7.4% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Pheton has higher earnings, but lower revenue than IRIDEX.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pheton$450K9.74-$660KN/AN/A
IRIDEX$49.74M0.36-$8.91M-$0.33-3.23

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
IRIDEX
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Pheton beats IRIDEX on 7 of the 10 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTHL vs. The Competition

MetricPhetonMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$4.38M$8.52B$6.15B$10.63B
Dividend YieldN/A2.14%5.72%4.85%
P/E RatioN/A76.6129.3627.28
Price / Sales9.7433.84494.39188.33
Price / CashN/A21.3125.8230.35
Price / Book0.717.0412.516.69
Net Income-$660K$247.60M$3.32B$276.34M
7 Day Performance-2.06%0.31%2.04%0.16%
1 Month Performance-22.61%-0.80%8.75%3.95%
1 Year Performance-86.35%11.29%63.75%33.43%

Pheton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTHL
Pheton
N/A$0.67
+5.9%
N/A-86.1%$4.38M$450K0.0011News Coverage
Positive News
Short Interest ↓
Gap Down
IRIX
IRIDEX
0.4788 of 5 stars
$1.05
+0.5%
N/A-35.4%$17.67M$48.67M-3.17120
BTCY
Biotricity
N/A$0.61
+3.6%
N/A+85.2%$16.36M$12.06M-0.5740Gap Up
ICU
SeaStar Medical
0.2188 of 5 stars
$0.55
-4.7%
N/A-84.7%$15.96M$140K-0.212
HSDT
Solana
0.4205 of 5 stars
$16.07
+9.3%
N/A-98.3%$15.84M$520K-0.0130News Coverage
Gap Up
ALUR
Allurion Technologies
2.0511 of 5 stars
$2.02
+0.8%
$9.25
+359.1%
-88.5%$15.52M$32.11M-0.16501
SINT
Sintx Technologies
2.6467 of 5 stars
$4.05
-2.2%
$25.00
+517.3%
+3.1%$14.85M$2.89M-0.0840News Coverage
Analyst Upgrade
Short Interest ↓
CODX
Co-Diagnostics
4.3906 of 5 stars
$0.38
+1.5%
$5.50
+1,329.7%
-73.0%$14.60M$3.91M-0.33100Short Interest ↓
NVNO
enVVeno Medical
0.9022 of 5 stars
$0.74
-0.1%
N/A-76.8%$14.28MN/A-0.6230
IINN
Inspira Technologies OXY B.H.N.
2.5092 of 5 stars
$1.16
+2.7%
$2.00
+72.4%
-19.3%$14.26MN/A0.0020News Coverage
Analyst Downgrade
Short Interest ↓
CTCX
Carmell
N/A$0.62
-18.4%
N/A+7.7%$12.96M$32.84K0.0014

Related Companies and Tools


This page (NASDAQ:PTHL) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners